Public Health Leadership Paramount to Emerging Coronavirus Pandemic
FAU researchers and collaborators have published a commentary in 'The American Journal of Medicine' about the urgent need for public health leadership in the wake of the emerging coronavirus pandemic.
FAU Makes 'U.S. News & World Report' Lists for Best Graduate Programs
More than one dozen FAU graduate programs are included in the latest U.S. News & World Report's 2021 "Best Graduate Programs."
FAU Emergency Medicine Resident Physicians Train for Coronavirus
With seven reported cases in Florida to-date, FAU emergency medicine resident physicians prepared for the threat of a coronavirus contagion using a simulated or "mock" disaster scenario at FORTS Medical.
Could This Toothpaste Prevent a Heart Attack or Stroke?
A study by FAU and collaborators shows Plaque HD®, the first toothpaste that identifies plaque so that it can be removed with directed brushing, significantly reduces inflammation throughout the body.
Neighborhood Features and Genetic Risk Interact to Affect Cognition
A new FAU study is the first to examine how neighborhood environment affects cognition in older adults based on their genetic risk for Alzheimer's disease and dementia.
Researchers Challenge New Guidelines on Aspirin in Primary Prevention
New guidelines recommend aspirin use in primary prevention for people ages 40 to 70 years old who are at higher risk of a first cardiovascular event, but not for those over 70.
Oh My Aching Back: Do Yoga, Tai Chi or Qigong Help?
Researchers provide a comprehensive review of the effects of movement-based mind-body interventions on chronic low back pain.
Choosing Common Pain Relievers: It's Complicated
FAU Schmidt College of Medicine researchers examine benefits and risks of nonsteroidal anti-inflammatory drugs to provide guidance to health care providers and their patients in their clinical decision-making.
Study Shows New Way to Treat Stroke Using an Already FDA-Approved Drug
Researchers from FAU's Schmidt College of Medicine are the first to report on the neuroprotective properties of granulocyte colony-stimulating factor, an already FDA-approved drug.
Genetic Testing in Diverse Young Breast Cancer Patients over a Decade
Researchers examined racial and ethnic differences in genetic testing frequency and results among diverse breast cancer patients diagnosed at age 50 or younger from January 2007 to December 2017.